Omega Healthcare Investors (OHI) to Release Earnings on Wednesday

Omega Healthcare Investors (NYSE:OHI - Get Free Report) is expected to be announcing its Q4 2024 earnings results after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $0.41 per share and revenue of $226.22 million for the quarter. Omega Healthcare Investors has set its FY 2025 guidance at 2.900-2.980 EPS.Persons that wish to listen to the company's earnings conference call can do so using this link.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 EPS for the quarter, topping the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a net margin of 34.41% and a return on equity of 8.83%. On average, analysts expect Omega Healthcare Investors to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Omega Healthcare Investors Trading Down 0.6 %

OHI traded down $0.25 during trading on Thursday, hitting $38.07. 3,540,789 shares of the stock traded hands, compared to its average volume of 1,925,878. The firm has a market capitalization of $10.28 billion, a P/E ratio of 28.00, a price-to-earnings-growth ratio of 1.08 and a beta of 0.99. Omega Healthcare Investors has a 12-month low of $27.74 and a 12-month high of $44.42. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The firm has a 50-day moving average of $38.11 and a 200 day moving average of $39.07.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Monday, February 10th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 7.04%. The ex-dividend date of this dividend is Monday, February 10th. Omega Healthcare Investors's dividend payout ratio (DPR) is currently 197.06%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on OHI. Mizuho lifted their price target on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the company a "neutral" rating in a report on Thursday, December 5th. BNP Paribas upgraded shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price target on the stock in a research report on Thursday, October 31st. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a research note on Friday, October 18th. They issued a "buy" rating and a $45.00 price target for the company. Royal Bank of Canada upped their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a report on Monday, November 11th. Finally, BMO Capital Markets upgraded Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price target on the stock in a research report on Monday, December 9th. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, Omega Healthcare Investors currently has an average rating of "Moderate Buy" and an average target price of $41.67.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.